Skip to content

WHEAT GERM FOR THE TREATMENT OF PARASITES

WHEAT GERM FOR THE TREATMENT OF PARASITES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-031-01
Enrollment
Unknown
Registered
2001-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Symptomatic: Group A Type of group
Wheat germ 50 mg / k / d + tinidazole. Group name:Asymptomatic: Group B Type of group
Placebo

Sponsors

INSTITUTO DE INVESTIGACION NUTRICIONAL,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Giardia lamblia confirmed by ELISA. • Age greater than twelve months and less than or equal to 5 years (exceptionally older children). • Plan to reside in Lima for more than 2 months. • Symptomatic: Gastrointestinal symptom: diarrhea, abdominal pain, cramps. Abdominal distention, vomiting • Asymptomatic: No gastrointestinal symptoms

Exclusion criteria

Exclusion criteria: Symptomatic: • Dysentery (nalidixic acid will be indicated) • Severe diarrhea requiring hospitalization. • Significant medical condition (pneumonia, cancer, etc.) • Immuno suppressive therapy (eg steroids greater than or equal to 2mg / kg / d). • While you are taking an antibiotic for some reason. • Prior enrollment. • Wheat allergy. Asymptomatic: • Diarrhea. • Bloating or abdominal pain, vomiting. • Other gastrointestinal symptoms. • The other criteria of the symptomatic patient are repeated

Design outcomes

Primary

MeasureTime frame
Outcome name:Clinical evolution: based on the selection of data that will be evaluated according to the pre-established group, Stool test by ELISA test for giardia Measure:Frequency of parasitosis Timepoints:Durinf and after treatment

Secondary

MeasureTime frame
Outcome name:Stool test by ELISA test for giardia, microscope and coproculture according to the group. Blood test: hemoglobin. Measure:Laboratory Exams Timepoints:During and after treatment ; Outcome name:Age and education of parents, type of house (walls, floor) and basic services, number of people in the house, siblings. Measure:Sociodemographic information Timepoints:Before treatment ; Outcome name:Based on the selection of data that will be evaluated according to the pre-established group Measure:Clinical evolution Timepoints:During treatment

Outcome results

None listed

Source: REPEC (via WHO ICTRP)